Korelasi HbA1c, APTT dan PT Pada Pasien Diabetes Militus tipe 2 Sebagai Prediktor Hiperkoagulasi Di Rumah Sakit Umum Gambiran  Kota Kediri

fathul hasanah; Anna Siga; Shela Sari

doi:10.56399/jst.v2i2.24

Penulis

fathul hasanah institut ilmu kesehatan bhakti wiyata
Fiscarina Institut Ilmu Kesehatan Bhakti Wiyata
Dian Institut Ilmu Kesehatan Bhakti Wiyata

DOI:

https://doi.org/10.56399/jst.v2i2.24

Kata Kunci:

Diabetes Mellitus, HbA1c, APTT; PT

Abstrak

The state of chronic hyperglycemia in DM can cause an increase in blood clotting factor levels, these affect the hemostasis system, and become the basis for the emergence of a hypercoagulable state in DM patients, hypercoagulation can be identified by examination of clotting factors, these are PT and APTT. The purpose of this study was to determine the relationship between HbA1c, APTT, and PT in diabetes mellitus patients as a predictor of hypercoagulation. The design in this study uses a cross-sectional study. The population in this study were 108 DM patients at the Gambiran General Hospital, Kediri City with a total sample of 20 Type 2 Diabetes Mellitus patients, Sampling technique was purposive with inclusion criteria: type 2 DM patients with HbA1c levels > 6.4% and exclusion: Type I DM patients, Type 2 DM patients with anticoagulants treatment and type 2 DM patients with liver disease. The average HbA1c level was 9.35%, the maximum level was 14% and the minimum level was 6.5%. The average PT time was 12.6 seconds with the longest time being 14.9 seconds and the fastest time being 10.4 seconds. The results of the APTT examination have an average of 26.2 seconds with the longest time being 35.2 seconds and the fastest time being 22.7 seconds. HbA1c with APTT has no correlation, this is indicated by a p-value of 0.794 or > 0.05 and r = 0.062. HbA1c with PT there is a correlation with p-value 0.005 or <0.05 and a moderate level of correlation r = 0.598. The conclusion of this study, HbA1c in type 2 DM patients did not correlate with APTT, whereas have positively correlated with PT that it could be interpreted when HbA1c levels increased then the PT time would be prolonged or hypocoagulation

Referensi

Acang N, Jalil FD. 1993. Hypercoagulation in diabetes mellitus. South-east Asian J Trop Med Public Health;24:263-6.

American Diabetes Association. 2015. Standards Of Medical Care IN Diabetes-2015, Diabetes Care., 38(1): S01-S94.

Bantilan RM, Mantiri GA, Manoppo F. 2014. Hubungan Antara Kadar HbA1C Dengan Nilai Agregasi Trombosit Pada pasien Diabetes Melitus Tipe 2 di RSUP Prof. DR. R.D. Kandao Manado. J.e-Biomedik (eBM); 2(1): 1–6.

Carmassi F, Morale M, Puccetti R, De Negri F, Monzani F, Navakesi R. 1992. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. Thromb Res.; 67:643-54

Collier A, Rumley A, Rumley AG, Paterson JR, Leach JP, Lowe GD, Small M. 1992. Free radical activity and hemostatic factors in NIDDM patients with and without micoalbuminuria. Diabetes;41:909- 13.

Dewi Prasetyani DM. 2019. Analisis Faktor Yang Mempengaruhi Kejadian Neuropati Diabetik Pada Pasien Diabetes Mellitus Tipe 2. Viva Med J Kesehatan, Kebidanan, dan Keperawatan; Volume 12/:1–12

Dhule S, Gawali S. 2014. Platelet aggregation and clotting time in type 2 diabetic male. Nat.Physiol. Pharm Pharmacol;4:96-8

Erem C, lua AH, Ovalia UC, Ersoza O, Ukinca K, Telatar OD. 2005. Coagulation and Fibrinolysis Parameters in Type 2 Diabetic Patients with and without Diabetic Vascular Complications. Med Princ Pract.; 14: 2230.

Hariani, Abd.Hady J, Nuraeni Jalil dan Surya Arya Putra. 2020. Hubungan Lama Menderita dan Komplikasi DM Terhadap Kualitas Hidup Pasien DM Tipe 2 di Wilayah Puskesmas Batua Kota Makassar. Makassar : Poltekes Makassar.

Ida Ayu Trisna Wulandari, Sianny Herawati dan I Nyoman Wande. 2020. Gambaran Kadar HbA1c Pada Pasien Diabetes Melitus Tipe II Di RSUP Sanglah Periode Juli-Desember 2017. Departemen Patologi Klinik Fakultas Kedokteran Universitas Udayana.

Indranila KS. 2016. Molecular Aspect Correlation Between Glycated Hemoglobin (HBA1C), Prothrombin Time (PT) And Activated Partial Thromboplastin Time (APTT) On Type 2 Diabetes Mellitus (T2DM). Indonesian Journal Of Clinical Pathology And Medical Laboratory. 23(1): 1–6. p-ISSN 0854-4263 | e-ISSN 4277-4685

Isnaini N, Ratnasari R. 2018. Faktor risiko mempengaruhi kejadian Diabetes mellitus tipe dua. J Kebidanan dan Keperawatan Aisyiyah ;14(1):59–68.

Laffan, M.A., Brandshow, A.E. 1995. Investigation of haemostasis. In: practical haematology, Dacie, J.V, Lewis, S.M. (eds), 8th edition. Edinburgh, Churchill Livingstone;297-310.

Lippi G, Franchini M, Targher G, Montagnana M, Salvagno G, Guidi G, Emmanuel J. and Favaloro. 2009. Epidemiological association between fasting plasma glucose and shortened APTT. Clinical Biochemistry.; 42:118-20.

Mitchel RN. 2015. Hemodynamic abnormalities, thromboembolism,and shock. In Kumar V, Abbas AK, Aster JC. Robbins Basic Pathology. 9th Ed., St Louis, Sounders Elsevier; 71–94

Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ et al. 2008. Translating the A1c assay into estimated average glucose values. Diabetes Care. 2008; 31(8): 1473–1478.

Ng VL. 2009. Prothtombin time and Partial Thromboplastin Time Assay Consideration. Clin Lab Med; 29(2): 253–263.

Pangemanan dan Malayu. 2014. Analisis Faktor Resiko Penyebab Terjadinya DM Tipe 2 Pada Wanita Usia Produktif Di Puskesmas Wawonasa. Jurnal e-Biomedik (eBM). Volume 2 Nomor 2.

Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL. 2010. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N. Engl. J. Med;362:800–11.